Evidence map›Paper›PMID 38132331›Full record

ArticleBiology2023

Harnessing Plant Sugar Metabolism for Glycoengineering.

Sophia N Tang, Collin R Barnum, Matthew J Szarzanowicz, Sasilada Sirirungruang, Patrick M Shih

Open access · goldAbstract read
In one paragraph

Article in Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sophia N TangDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720, USA.ORCID 0000-0003-1921-7886
Collin R BarnumBiochemistry, Molecular, Cellular and Developmental Biology Graduate Group, University of California, Davis, CA 95616, USA.ORCID 0000-0003-0978-7105
Matthew J SzarzanowiczFeedstocks Division, Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0009-0003-4398-5196
Sasilada SirirungruangFeedstocks Division, Joint BioEnergy Institute, Emeryville, CA 94608, USA.ORCID 0000-0002-2624-5124
Patrick M ShihFeedstocks Division, Joint BioEnergy Institute, Emeryville, CA 94608, USA.
Lawrence Berkeley National Laboratory · USUniversity of California, Davis · US

Funding

United States Department of Energy DEAC02-05CH11231
6 · The paper itself

Abstract

Plants possess an innate ability to generate vast amounts of sugar and produce a range of sugar-derived compounds that can be utilized for applications in industry, health, and agriculture. Nucleotide sugars lie at the unique intersection of primary and specialized metabolism, enabling the biosynthesis of numerous molecules ranging from small glycosides to complex polysaccharides. Plants are tolerant to perturbations to their balance of nucleotide sugars, allowing for the overproduction of endogenous nucleotide sugars to push flux towards a particular product without necessitating the re-engineering of upstream pathways. Pathways to produce even non-native nucleotide sugars may be introduced to synthesize entirely novel products. Heterologously expressed glycosyltransferases capable of unique sugar chemistries can further widen the synthetic repertoire of a plant, and transporters can increase the amount of nucleotide sugars available to glycosyltransferases. In this opinion piece, we examine recent successes and potential future uses of engineered nucleotide sugar biosynthetic, transport, and utilization pathways to improve the production of target compounds. Additionally, we highlight current efforts to engineer glycosyltransferases. Ultimately, the robust nature of plant sugar biochemistry renders plants a powerful chassis for the production of target glycoconjugates and glycans.

Indexed as

carbohydratesglycoconjugatesglycoengineeringglycosidesmetabolic engineeringnucleotide sugars

Identifiers

PMID38132331
PMCPMC10741112
OpenAlexW4389481652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.